186 related articles for article (PubMed ID: 32473019)
1. RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice.
Duggan BM; Cavallari JF; Foley KP; Barra NG; Schertzer JD
Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32473019
[TBL] [Abstract][Full Text] [Related]
2. Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.
Cavallari JF; Barra NG; Foley KP; Lee A; Duggan BM; Henriksbo BD; Anhê FF; Ashkar AA; Schertzer JD
Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E579-E585. PubMed ID: 32101030
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia.
Duggan BM; Foley KP; Henriksbo BD; Cavallari JF; Tamrakar AK; Schertzer JD
Sci Rep; 2017 May; 7(1):1578. PubMed ID: 28484277
[TBL] [Abstract][Full Text] [Related]
4. Joint NOD2/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis.
Vieira SM; Cunha TM; França RF; Pinto LG; Talbot J; Turato WM; Lemos HP; Lima JB; Verri WA; Almeida SC; Ferreira SH; Louzada-Junior P; Zamboni DS; Cunha FQ
J Immunol; 2012 May; 188(10):5116-22. PubMed ID: 22491249
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
Canning P; Ruan Q; Schwerd T; Hrdinka M; Maki JL; Saleh D; Suebsuwong C; Ray S; Brennan PE; Cuny GD; Uhlig HH; Gyrd-Hansen M; Degterev A; Bullock AN
Chem Biol; 2015 Sep; 22(9):1174-84. PubMed ID: 26320862
[TBL] [Abstract][Full Text] [Related]
6. Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo.
Fan YH; Roy S; Mukhopadhyay R; Kapoor A; Duggal P; Wojcik GL; Pass RF; Arav-Boger R
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7818-E7827. PubMed ID: 27856764
[TBL] [Abstract][Full Text] [Related]
7. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
Hrdinka M; Schlicher L; Dai B; Pinkas DM; Bufton JC; Picaud S; Ward JA; Rogers C; Suebsuwong C; Nikhar S; Cuny GD; Huber KV; Filippakopoulos P; Bullock AN; Degterev A; Gyrd-Hansen M
EMBO J; 2018 Sep; 37(17):. PubMed ID: 30026309
[TBL] [Abstract][Full Text] [Related]
8. Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.
Shiny A; Regin B; Balachandar V; Gokulakrishnan K; Mohan V; Babu S; Balasubramanyam M
Cytokine; 2013 Nov; 64(2):564-70. PubMed ID: 24018334
[TBL] [Abstract][Full Text] [Related]
9. Increased NOD1, but not NOD2, activity in subcutaneous adipose tissue from patients with metabolic syndrome.
Zhou YJ; Liu C; Li CL; Song YL; Tang YS; Zhou H; Li A; Li Y; Weng Y; Zheng FP
Obesity (Silver Spring); 2015 Jul; 23(7):1394-400. PubMed ID: 26052894
[TBL] [Abstract][Full Text] [Related]
10. Postbiotics engage IRF4 in adipocytes to promote sex-dependent changes in blood glucose during obesity.
Duggan BM; Singh AM; Chan DY; Schertzer JD
Physiol Rep; 2022 Aug; 10(16):e15439. PubMed ID: 35993451
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
12. NOD1 activators link innate immunity to insulin resistance.
Schertzer JD; Tamrakar AK; Magalhães JG; Pereira S; Bilan PJ; Fullerton MD; Liu Z; Steinberg GR; Giacca A; Philpott DJ; Klip A
Diabetes; 2011 Sep; 60(9):2206-15. PubMed ID: 21715553
[TBL] [Abstract][Full Text] [Related]
13. A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.
Heim VJ; Dagley LF; Stafford CA; Hansen FM; Clayer E; Bankovacki A; Webb AI; Lucet IS; Silke J; Nachbur U
EMBO Rep; 2020 Nov; 21(11):e50400. PubMed ID: 32954645
[TBL] [Abstract][Full Text] [Related]
14. In vivo inhibition of RIPK2 kinase alleviates inflammatory disease.
Tigno-Aranjuez JT; Benderitter P; Rombouts F; Deroose F; Bai X; Mattioli B; Cominelli F; Pizarro TT; Hoflack J; Abbott DW
J Biol Chem; 2014 Oct; 289(43):29651-64. PubMed ID: 25213858
[TBL] [Abstract][Full Text] [Related]
15. Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling.
Nikhar S; Siokas I; Schlicher L; Lee S; Gyrd-Hansen M; Degterev A; Cuny GD
Eur J Med Chem; 2021 Apr; 215():113252. PubMed ID: 33601309
[TBL] [Abstract][Full Text] [Related]
16. Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice.
O'Harte FP; Ng MT; Lynch AM; Conlon JM; Flatt PR
Diabetes Obes Metab; 2016 Oct; 18(10):1013-24. PubMed ID: 27357054
[TBL] [Abstract][Full Text] [Related]
17. Receptor-interacting protein kinase 2 contributes to host innate immune responses against Fusobacterium nucleatum in macrophages and decidual stromal cells.
Park JY; Lee TS; Noh EJ; Jang AR; Ahn JH; Kim DY; Jung DH; Song EJ; Lee YJ; Lee YJ; Lee SK; Park JH
Am J Reprod Immunol; 2021 Jul; 86(1):e13403. PubMed ID: 33580557
[TBL] [Abstract][Full Text] [Related]
18. p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans.
Ciciliot S; Albiero M; Menegazzo L; Poncina N; Scattolini V; Danesi A; Pagnin E; Marabita M; Blaauw B; Giorgio M; Trinei M; Foletto M; Prevedello L; Nitti D; Avogaro A; Fadini GP
Diabetologia; 2015 Oct; 58(10):2352-60. PubMed ID: 26122877
[TBL] [Abstract][Full Text] [Related]
19. NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes.
Zhao L; Hu P; Zhou Y; Purohit J; Hwang D
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E587-98. PubMed ID: 21693690
[TBL] [Abstract][Full Text] [Related]
20. The expression of CCN2, IQSEC, RSPO1, DNAJC15, RIPK2, IL13RA2, IRS1, and IRS2 genes in blood of obese boys with insulin resistance.
Minchenko DO; Davydov VV; Budreiko OA; Moliavko OS; Kulieshova DK; Tiazhka OV; Minchenko OH
Fiziol Zh (1994); 2015; 61(1):10-8. PubMed ID: 26040030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]